The in vitro diagnostic packaging market size has grown strongly in recent years. It will grow from $10.04 billion in 2025 to $10.82 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising adoption of in vitro diagnostic testing, expansion of clinical laboratory infrastructure, increasing demand for accurate disease diagnosis, growth of global healthcare expenditure, availability of advanced packaging materials.
The in vitro diagnostic packaging market size is expected to see strong growth in the next few years. It will grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing growth of point-of-care diagnostics, rising focus on sustainable medical packaging, expansion of molecular diagnostics testing, increasing investments in healthcare infrastructure, growing emphasis on supply chain safety and integrity. Major trends in the forecast period include increasing demand for sterile and contamination-resistant packaging, rising adoption of tamper-evident ivd packaging solutions, growing use of high-barrier plastic and glass materials, expansion of customized packaging for diagnostic kits, enhanced focus on regulatory-compliant packaging designs.
The increasing incidence and prevalence of chronic diseases and infectious conditions are expected to drive the growth of the in vitro diagnostic (IVD) packaging market in the coming years. Chronic diseases and infections are long-term health conditions or illnesses caused by pathogens that persist over time and often result in prolonged medical complications. The rising burden of these conditions is largely linked to greater exposure to pathogens and lifestyle-related factors, including unhealthy diets and insufficient physical activity. In vitro diagnostic packaging plays a critical role in addressing chronic diseases and infections by ensuring the safe, dependable, and efficient distribution of diagnostic tests that support early detection and timely treatment, thereby improving patient outcomes and overall healthcare efficiency. For example, in March 2025, according to data released by the UK Health Security Agency, a UK-based executive body, 368 measles cases were reported in England in 2023, representing nearly a sevenfold increase compared to the 53 cases recorded in 2022, with the West Midlands and London accounting for 44% and 33% of cases, respectively. Therefore, the rising incidence and prevalence of chronic diseases and infections are contributing to the expansion of the in vitro diagnostic packaging market.
Leading companies operating in the in vitro diagnostic packaging market are prioritizing the development of innovative solutions, such as sustainable IVD packaging, to improve environmental performance and reduce the ecological footprint of diagnostic product packaging. Sustainable IVD packaging involves the use of environmentally friendly materials and manufacturing practices that minimize environmental impact while preserving product safety and integrity. For instance, in March 2025, Oxford Gene Technology IP Limited, a UK-based supplier of diagnostic genomic solutions, launched an environmentally sustainable packaging solution for its CytoCell product range. This newly developed packaging incorporates biodegradable and recyclable materials, reflecting the growing industry emphasis on sustainability. In addition to supporting eco-friendly disposal, the redesigned packaging simplifies laboratory workflows through streamlined and easily accessible digital documentation, reinforcing the company’s commitment to waste reduction and operational efficiency within clinical and diagnostic environments.
In July 2023, STRATEC SE, a Germany-based provider of fully automated analyzer systems and complex consumables for in vitro diagnostics, acquired Natech Plastics, Inc. for US$30 million plus an earn-out. Through this acquisition, STRATEC aims to strengthen its IVD consumables and packaging capabilities by incorporating Natech’s smart polymer-based consumables and broadening its range of diagnostic consumables for medical technology and life sciences applications. Natech Plastics, Inc. is a US-based company specializing in smart polymer-based consumables, including injection-molded components and custom tubes for in vitro diagnostics and medical use.
Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc, Corning Incorporated, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd., Thousand Peak Glass Bottle Co. Ltd., Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services Inc., SGD Pharma, Nipro Corporation.
North America was the largest region in the in vitro diagnostic packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the in vitro diagnostic packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the in vitro diagnostic packaging market by increasing the cost of imported plastics, specialty glass, composite materials, and precision molding equipment used in bottles, vials, cartridges, and diagnostic cassettes. Packaging manufacturers and diagnostic kit producers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces pricing pressure on export-oriented packaging production. These tariffs are increasing packaging costs and affecting pricing strategies for diagnostic manufacturers. However, they are also encouraging domestic material sourcing, localized packaging production, and investments in recyclable and alternative packaging materials that strengthen long-term supply chain resilience.
The in vitro diagnostic packaging market research report is one of a series of new reports that provides in vitro diagnostic packaging market statistics, including in vitro diagnostic packaging industry global market size, regional shares, competitors with a in vitro diagnostic packaging market share, detailed in vitro diagnostic packaging market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostic packaging industry. This in vitro diagnostic packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
In vitro diagnostic (IVD) packaging involves specialized materials and containers designed to store, protect, and transport IVD devices. These devices are used to perform tests on biological samples, such as blood or tissue, for diagnosing diseases or monitoring health conditions. Proper packaging is essential to maintain the integrity and reliability of these devices throughout their lifecycle, safeguarding them from contamination, damage, and environmental influences.
In vitro diagnostic packaging consists of primary, secondary, and tertiary packaging types. Primary packaging refers to the direct container or material that encloses and protects the diagnostic product, ensuring its safety, integrity, and functionality before use. Examples of primary packaging include bottles, vials, tubes, petri dishes, closures, and others, made from materials such as plastic, glass, metal, and composites. These products are utilized in fields such as biochemistry, microbiology, immunology, and molecular diagnostics by end users such as hospitals, laboratories, academic institutions, and others.
The in vitro diagnostic packaging market consists of sales of sterile containers, tamper-evident seals, temperature-controlled packaging, and moisture-resistant materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The in vitro diagnostic packaging market size is expected to see strong growth in the next few years. It will grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing growth of point-of-care diagnostics, rising focus on sustainable medical packaging, expansion of molecular diagnostics testing, increasing investments in healthcare infrastructure, growing emphasis on supply chain safety and integrity. Major trends in the forecast period include increasing demand for sterile and contamination-resistant packaging, rising adoption of tamper-evident ivd packaging solutions, growing use of high-barrier plastic and glass materials, expansion of customized packaging for diagnostic kits, enhanced focus on regulatory-compliant packaging designs.
The increasing incidence and prevalence of chronic diseases and infectious conditions are expected to drive the growth of the in vitro diagnostic (IVD) packaging market in the coming years. Chronic diseases and infections are long-term health conditions or illnesses caused by pathogens that persist over time and often result in prolonged medical complications. The rising burden of these conditions is largely linked to greater exposure to pathogens and lifestyle-related factors, including unhealthy diets and insufficient physical activity. In vitro diagnostic packaging plays a critical role in addressing chronic diseases and infections by ensuring the safe, dependable, and efficient distribution of diagnostic tests that support early detection and timely treatment, thereby improving patient outcomes and overall healthcare efficiency. For example, in March 2025, according to data released by the UK Health Security Agency, a UK-based executive body, 368 measles cases were reported in England in 2023, representing nearly a sevenfold increase compared to the 53 cases recorded in 2022, with the West Midlands and London accounting for 44% and 33% of cases, respectively. Therefore, the rising incidence and prevalence of chronic diseases and infections are contributing to the expansion of the in vitro diagnostic packaging market.
Leading companies operating in the in vitro diagnostic packaging market are prioritizing the development of innovative solutions, such as sustainable IVD packaging, to improve environmental performance and reduce the ecological footprint of diagnostic product packaging. Sustainable IVD packaging involves the use of environmentally friendly materials and manufacturing practices that minimize environmental impact while preserving product safety and integrity. For instance, in March 2025, Oxford Gene Technology IP Limited, a UK-based supplier of diagnostic genomic solutions, launched an environmentally sustainable packaging solution for its CytoCell product range. This newly developed packaging incorporates biodegradable and recyclable materials, reflecting the growing industry emphasis on sustainability. In addition to supporting eco-friendly disposal, the redesigned packaging simplifies laboratory workflows through streamlined and easily accessible digital documentation, reinforcing the company’s commitment to waste reduction and operational efficiency within clinical and diagnostic environments.
In July 2023, STRATEC SE, a Germany-based provider of fully automated analyzer systems and complex consumables for in vitro diagnostics, acquired Natech Plastics, Inc. for US$30 million plus an earn-out. Through this acquisition, STRATEC aims to strengthen its IVD consumables and packaging capabilities by incorporating Natech’s smart polymer-based consumables and broadening its range of diagnostic consumables for medical technology and life sciences applications. Natech Plastics, Inc. is a US-based company specializing in smart polymer-based consumables, including injection-molded components and custom tubes for in vitro diagnostics and medical use.
Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc, Corning Incorporated, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd., Thousand Peak Glass Bottle Co. Ltd., Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services Inc., SGD Pharma, Nipro Corporation.
North America was the largest region in the in vitro diagnostic packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the in vitro diagnostic packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the in vitro diagnostic packaging market by increasing the cost of imported plastics, specialty glass, composite materials, and precision molding equipment used in bottles, vials, cartridges, and diagnostic cassettes. Packaging manufacturers and diagnostic kit producers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces pricing pressure on export-oriented packaging production. These tariffs are increasing packaging costs and affecting pricing strategies for diagnostic manufacturers. However, they are also encouraging domestic material sourcing, localized packaging production, and investments in recyclable and alternative packaging materials that strengthen long-term supply chain resilience.
The in vitro diagnostic packaging market research report is one of a series of new reports that provides in vitro diagnostic packaging market statistics, including in vitro diagnostic packaging industry global market size, regional shares, competitors with a in vitro diagnostic packaging market share, detailed in vitro diagnostic packaging market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostic packaging industry. This in vitro diagnostic packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
In vitro diagnostic (IVD) packaging involves specialized materials and containers designed to store, protect, and transport IVD devices. These devices are used to perform tests on biological samples, such as blood or tissue, for diagnosing diseases or monitoring health conditions. Proper packaging is essential to maintain the integrity and reliability of these devices throughout their lifecycle, safeguarding them from contamination, damage, and environmental influences.
In vitro diagnostic packaging consists of primary, secondary, and tertiary packaging types. Primary packaging refers to the direct container or material that encloses and protects the diagnostic product, ensuring its safety, integrity, and functionality before use. Examples of primary packaging include bottles, vials, tubes, petri dishes, closures, and others, made from materials such as plastic, glass, metal, and composites. These products are utilized in fields such as biochemistry, microbiology, immunology, and molecular diagnostics by end users such as hospitals, laboratories, academic institutions, and others.
The in vitro diagnostic packaging market consists of sales of sterile containers, tamper-evident seals, temperature-controlled packaging, and moisture-resistant materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. in Vitro Diagnostic Packaging Market Characteristics
3. in Vitro Diagnostic Packaging Market Supply Chain Analysis
4. Global in Vitro Diagnostic Packaging Market Trends and Strategies
5. in Vitro Diagnostic Packaging Market Analysis of End Use Industries
7. Global in Vitro Diagnostic Packaging Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global in Vitro Diagnostic Packaging Total Addressable Market (TAM) Analysis for the Market
9. in Vitro Diagnostic Packaging Market Segmentation
10. in Vitro Diagnostic Packaging Market Regional and Country Analysis
11. Asia-Pacific in Vitro Diagnostic Packaging Market
12. China in Vitro Diagnostic Packaging Market
13. India in Vitro Diagnostic Packaging Market
14. Japan in Vitro Diagnostic Packaging Market
15. Australia in Vitro Diagnostic Packaging Market
16. Indonesia in Vitro Diagnostic Packaging Market
17. South Korea in Vitro Diagnostic Packaging Market
18. Taiwan in Vitro Diagnostic Packaging Market
19. South East Asia in Vitro Diagnostic Packaging Market
20. Western Europe in Vitro Diagnostic Packaging Market
21. UK in Vitro Diagnostic Packaging Market
22. Germany in Vitro Diagnostic Packaging Market
23. France in Vitro Diagnostic Packaging Market
24. Italy in Vitro Diagnostic Packaging Market
25. Spain in Vitro Diagnostic Packaging Market
26. Eastern Europe in Vitro Diagnostic Packaging Market
27. Russia in Vitro Diagnostic Packaging Market
28. North America in Vitro Diagnostic Packaging Market
29. USA in Vitro Diagnostic Packaging Market
30. Canada in Vitro Diagnostic Packaging Market
31. South America in Vitro Diagnostic Packaging Market
32. Brazil in Vitro Diagnostic Packaging Market
33. Middle East in Vitro Diagnostic Packaging Market
34. Africa in Vitro Diagnostic Packaging Market
36. in Vitro Diagnostic Packaging Market Competitive Landscape and Company Profiles
37. in Vitro Diagnostic Packaging Market Other Major and Innovative Companies
40. in Vitro Diagnostic Packaging Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
In Vitro Diagnostic Packaging Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses in vitro diagnostic packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for in vitro diagnostic packaging? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostic packaging market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Packaging Type: Primary Packaging; Secondary Packaging; Tertiary Packaging2) By Product: Bottles And Vials; Tubes; Petri Dishes; Closures; Other Products
3) By Material Type: Plastic; Glass; Metal; Composite Materials
4) By Application Area: Biochemistry; Microbiology; Immunology; Molecular Diagnostics
5) By End User: Hospitals; Laboratories; Academic Institutes; Other End Users
Subsegments:
1) By Primary Packaging: Cartridges; Microplates; Sample Collection Containers; Reagent Reservoirs; Diagnostic Cassettes; Dropper Bottles2) By Secondary Packaging: Folding Cartons; Paperboard Sleeves; Trays; Multi-Compartment Boxes; Label Sets; Instruction Leaflets
3) By Tertiary Packaging: Corrugated Shipping Boxes; Pallets; Insulated Shippers; Foam Inserts Or Cushioning; Tamper-Evident Seals; Bulk Transport Containers
Companies Mentioned: Thermo Fisher Scientific Inc.; Siemens Healthineers; Amcor plc; Corning Incorporated; QuidelOrtho Corporation; Bio-Rad Laboratories Inc.; ProAmpac; DiaSorin S.p.A.; Stevanato Group S.p.A.; Sarstedt AG & Co. KG; Greiner AG; Phillips Medisize; Scantibodies Laboratory Inc.; Sanner GmbH; DWK Life Sciences; MML Diagnostics Packaging Inc.; TCS Biosciences Ltd.; Thousand Peak Glass Bottle Co. Ltd.; Gerresheimer AG; SCHOTT AG; Berry Global Inc.; West Pharmaceutical Services Inc.; SGD Pharma; Nipro Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this In Vitro Diagnostic Packaging market report include:- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Amcor plc
- Corning Incorporated
- QuidelOrtho Corporation
- Bio-Rad Laboratories Inc.
- ProAmpac
- DiaSorin S.p.A.
- Stevanato Group S.p.A.
- Sarstedt AG & Co. KG
- Greiner AG
- Phillips Medisize
- Scantibodies Laboratory Inc.
- Sanner GmbH
- DWK Life Sciences
- MML Diagnostics Packaging Inc.
- TCS Biosciences Ltd.
- Thousand Peak Glass Bottle Co. Ltd.
- Gerresheimer AG
- SCHOTT AG
- Berry Global Inc.
- West Pharmaceutical Services Inc.
- SGD Pharma
- Nipro Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.82 Billion |
| Forecasted Market Value ( USD | $ 14.51 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
